Tremor Monitoring Device

Patients with tremor may have varying degrees of tremor at different times. The amplitude and frequency of tremor may change. The investigators observational study is intended to document this tremor.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Parkinson's Disease Basal Ganglia Diseases Brain Diseases Central Nervous System Diseases Essential Tremor Movement Disorders Nervous System Diseases Neurodegenerative Diseases Parkinson Disease Parkinsonian Disorders Synucleinopathies

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with tremor due to Parkinson's disease or Essential tremor

Exclusion criteria

Severe dementia

Treatment and study plan

Primary outcomes

Maximum linear acceleration of the forearm.

Time frame: Linear acceleration of the forearm will be measured for 15-60 minutes.

We will measure linear acceleration of the forearm in meter per second squared.

Secondary outcomes

Maximum angular velocity of the forearm.

Time frame: Maximum angular velocity of the forearm will be measured for 15-60 minutes.

We will measure angular velocityof the forearm in degrees per second.

Sponsors and collaborators

Lead sponsor

Rambam Health Care Campus

Other

Collaborators

Technion, Israel Institute of Technology

Registry information

Important dates

Study start: 2015
Primary completion: 2017
Study completion: 2017
First posted: Aug 14, 2015
Registry last updated: Oct 31, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed